New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 2, 2018 - Coherus BioSciences announced the FDA approval of Udenyca (pegfilgrastim-cbqv), biosimilar to Amgen’s Neulasta® (pegfilgrastim).
Download PDF
Return to publications
